Yuhuko Ichikawa
Overview
Explore the profile of Yuhuko Ichikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda J, Wada H, Kato T, Tanigaito Y, Hayashi K, Yamada K, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685640
: Routine activated partial thromboplastin time (APTT) and prothrombin time (PT) measurements do not indicate hypercoagulability in patients with acute myocardial infarction (AMI) and acute cerebral infarction (ACI). : Hypercoagulability...
2.
Wada H, Shiraki K, Yamamoto A, Kamon T, Masuda J, Ichikawa Y, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39408040
: Soluble C-type lectin-like receptor -2 (sCLEC-2) has been recognized as a marker of platelet activation, and attention has been drawn to formulas combining sCLEC-2 levels with platelet count and...
3.
Fukui S, Wada H, Ikeda K, Kobayashi M, Shimada Y, Nakazawa Y, et al.
Clin Appl Thromb Hemost
. 2024 Apr;
30:10760296241246002.
PMID: 38591954
Although hepatocellular carcinoma (HCC) is frequently associated with thrombosis, it is also associated with liver cirrhosis (LC) which causes hemostatic abnormalities. Therefore, hemostatic abnormalities in patients with HCC were examined...
4.
Kamon T, Wada H, Horie S, Inaba T, Okamoto K, Shiraki K, et al.
Clin Appl Thromb Hemost
. 2024 Feb;
30:10760296241232858.
PMID: 38403943
Acute cerebral infarction (ACI) includes atherosclerotic and cardiogenic ACI and involves a thrombotic state, requiring antithrombotic treatment. However, the thrombotic state in ACI cannot be evaluated using routine hemostatic examinations....
5.
Yamamoto A, Wada H, Tomida M, Ichikawa Y, Ezaki M, Shiraki K, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443690
Materials And Methods: The diagnostic usefulness of sCLEC-2 and several formulas, including sCLEC-2xD-dimer, sCLEC-2/platelet count (sCLEC-2/PLT), and sCLEC-2/PLT × D-dimer (sCLEC-2xD-dimer/PLT), were evaluated among 38 patients with DIC, 39 patients...
6.
Ezaki M, Wada H, Ichikawa Y, Ikeda N, Shiraki K, Yamamoto A, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048680
Background: Soluble fibrin (SF) is a form of fibrinogen that is activated by thrombin and is considered to be useful for the diagnosis of the prethrombotic state or thrombosis. Methods:...
7.
Kamon T, Horie S, Inaba T, Ito N, Shiraki K, Ichikawa Y, et al.
Clin Appl Thromb Hemost
. 2023 Mar;
29:10760296231161591.
PMID: 36872898
A few studies concerning hypercoagulable states have sufficiently been reported in patients with acute cerebral infarction (ACI), as ACI is generally considered to be caused by platelet activation. Clot waveform...
8.
Fukui S, Ikeda K, Kobayashi M, Nishida K, Yamada K, Horie S, et al.
Mol Med Rep
. 2022 Dec;
27(1).
PMID: 36453231
The present study aimed to identify useful biomarkers to predict deterioration in patients with coronavirus disease 2019 (COVID‑19). A total of 201 COVID‑19 patients were classified according to their disease...
9.
Wada H, Yamamoto A, Tomida M, Ichikawa Y, Ezaki M, Masuda J, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207302
Background: The diagnostic criteria for disseminated intravascular coagulation (DIC) vary and are complicated and the cut-off values are different. Simple and quick diagnostic criteria for DIC are required in physicians...
10.
Wada H, Ichikawa Y, Ezaki M, Yamamoto A, Tomida M, Yoshida M, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207258
Although thrombosis in coronavirus disease 2019 (COVID-19) infection has attracted attention, the mechanism underlying its development remains unclear. The relationship between platelet activation and the severity of COVID-19 infection was...